Delivery Order SPE2DR25D7909-SPE2DR26FX7DP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,639.95 to AmerisourceBergen Drug Corp for Hydroxyzine 50 mg/ml vials. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, under firm fixed price terms with no set-aside designation. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Hydroxyzine 50 mg/mL vials under a firm fixed-price contract. The award, valued at $2,918.74, is set to be completed by July 15, 2025, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Hydroxyzine 50 mg/mL vials, with a contract ceiling value of $3,056.08. Issued on April 22, 2025, with an ultimate completion date of April 23, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside arrangement. The product will be delivered to the contractor's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $5,806.45 from the Medical Supply Chain, a defense-focused federal agency, for Hydroxyzine 50 mg/ml vials. The contract employs firm fixed-price terms with an ultimate completion date of June 2, 2025, and carries no set-aside designation. Performance will occur at the vendor's Conshohocken facility, leveraging the company's...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,461.56 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 4563519493 - Hydroxyzine 50 mg/mL vials, with a completion date of February 5, 2024. This delivery order contract is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $2,229.61 to supply 4563098754 Hydroxyzine 50 MG/ML Vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by December 15, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Hydroxyzine 50 mg/ml vials with a ceiling value of $4,453.78. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency Troop Support Medical awarded a $1,124 delivery order contract to Amerisourcebergen Drug Corporation for hydroxyzine 50 mg/ml vials. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between September 8-11, 2023. Amerisourcebergen will fulfill the requirements as the prime contractor under this small dollar, short-term order in support of the Defense Logistics Agency's medical supply chain responsibilities. No...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Hydroxyzine 50 mg/ml vials under a firm fixed-price contract valued at $1,081.71. The contract is a non-set-aside award with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical procurement...
- The U.S. government's Defense Logistics Agency (DLA) awarded a $3,026.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the supply of a specific medication, hydroxyzine 50 mg/mL vials, to support the DLA's medical supply chain operations. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp also holds a larger Indefinite...
- SPE2DR25D7909Indefinite Delivery Contract
- SPE2DR25D7909-SPE2DR26FX7DPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,645.98 to AmerisourceBergen Drug Corp for the supply of Hydroxyzine 50 mg/mL in vial format. The contract, which was competitively awarded without a set-aside designation, carries a firm fixed price and an ultimate completion date of December 24, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills delivery orders for medications spanning multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/22/25 |